In vitro and in vivo biocompatibility study of a hybrid nanoparticulate BMP-7/OP-1 delivery system

Keyphrases

• Delivery System 100%
• OP-1 100%
• Bone Morphogenetic Protein 100%
• Bone Morphogenetic protein-7 (BMP-7) 100%
• Biocompatibility Testing 100%
• Nanoparticulate 100%
• In Vitro Biocompatibility 100%
• In Vitro Cytotoxicity 100%
• Young Males 50%
• Inflammation 50%
• Monodisperse 50%
• Natural Polyelectrolytes 50%
• Alternating Layers 50%
• Nanosize 50%
• Blood Samples 50%
• Adverse Reactions 50%
• Body Weight Changes 50%
• Treatment Duration 50%
• Growth Factors 50%
• Extended Shelf Life 50%
• Protein Delivery System 50%
• Preosteoblast Cells 50%
• Immune Response 50%
• Colorimetry 50%
• Cationic Nanoparticles 50%
• Protein Loading 50%
• Pre-injection 50%
• Organ Function 50%
• MC3T3 50%
• Hematology Analyzer 50%
• Osteogenic Proteins 50%
• Wistar Rats 50%
• Cell Viability 50%
• Health Effects 50%
• Nanoparticles 50%
• Nanocarriers 50%
• Biochemical Analysis 50%
• Intramuscularly 50%
• Mouse Preosteoblasts 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Nanoparticle 100%
• Biocompatibility 100%
• Osteogenic Protein 1 100%
• Cytotoxicity 100%
• Inflammation 50%
• Adverse Event 50%
• Polyelectrolyte 50%
• Controlled Release 50%
• Cell Viability 50%
• Bone Morphogenetic Protein 50%
• Wistar Rat 50%
• Growth Factor 50%
• Protein Delivery 50%

Biochemistry, Genetics and Molecular Biology

• Cytotoxicity 100%
• Synapsin I 50%
• Immune Response 50%
• Growth Factor 50%
• Bone Morphogenetic Protein 50%
• Wistar Rat 50%
• Body Weight Change 50%
• Biochemical Analysis 50%
• Cell Viability 50%